Pliant Therapeutics, Inc.
PLRX
|
$12.86
-3.02%
-3.11%
270K
|
Health Technology
(0.0% 1d) (-9.2% 1m) (-54.3% 1y) (0.0% 2d) (-2.1% 3d) (-8.4% 7d) (59.68% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 774,675,803
http://www.pliantrx.com
Sec Filling | Patents | 62 employees
(US) Pliant Therapeutics, Inc. engages in the business of developing and commercializing novel therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. Pliant Therapeutics was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.
add to watch list Paper trade email alert is off
Press-releases
Cough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034 | DelveInsight
Published: 2024-04-03 (Crawled : 22:00) - prnewswire.com
PLRX | $12.86 -3.02% -3.11% 270K
|
Health Technology
|
| O: 1.87%
H: 3.4%
C: -1.02%
fibrosis therapeutics growth market
Pliant Therapeutics to Participate in Upcoming Investor Events
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
PLRX | $12.86 -3.02% -3.11% 270K
|
Health Technology
|
| O: -0.62%
H: 1.17%
C: 1.17%
therapeutics
Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference
Published: 2024-03-27 (Crawled : 14:30) - globenewswire.com
PLRX | $12.86 -3.02% -3.11% 270K
|
Health Technology
|
| O: 1.34%
H: 3.63%
C: 1.54%
conference international therapeutics
Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
PLRX | $12.86 -3.02% -3.11% 270K
|
Health Technology
|
| O: 0.0%
H: 6.88%
C: 4.2%
treatment fibrosis bexotegrast therapeutics
Nimbus Therapeutics Appoints Katharine Knobil, M.D., to Board of Directors
Published: 2024-03-12 (Crawled : 17:00) - biospace.com/
PLRX | $12.86 -3.02% -3.11% 270K
|
Health Technology
|
| O: 0.0%
H: 6.88%
C: 4.2%
MRKR | $4.4 0.23% 11K
|
Consumer Services
|
| O: -1.2%
H: 4.88%
C: 3.17%
therapeutics
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results
Published: 2024-02-27 (Crawled : 21:00) - globenewswire.com
PLRX | $12.86 -3.02% -3.11% 270K
|
Health Technology
|
| O: 4.59%
H: 0.0%
C: -7.67%
update therapeutics financial results
Pliant Therapeutics to Participate in Upcoming Investor Conferences
Published: 2024-02-26 (Crawled : 13:00) - globenewswire.com
PLRX | $12.86 -3.02% -3.11% 270K
|
Health Technology
|
| O: -0.3%
H: 4.27%
C: 1.4%
therapeutics
Pliant Therapeutics to Participate in Upcoming Investor Events - February 7, 2024
Published: 2024-02-07 (Crawled : 15:00) - biospace.com/
PLRX | $12.86 -3.02% -3.11% 270K
|
Health Technology
|
| O: 0.0%
H: 0.93%
C: -0.87%
therapeutics
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Published: 2024-02-04 (Crawled : 00:00) - globenewswire.com
PLRX | $12.86 -3.02% -3.11% 270K
|
Health Technology
|
| O: -3.62%
H: 0.0%
C: -5.78%
liver positive fibrosis bexotegrast trial therapeutics
Pliant Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 13:00) - globenewswire.com
PLRX | $12.86 -3.02% -3.11% 270K
|
Health Technology
|
| O: 0.28%
H: 3.44%
C: 0.28%
conference therapeutics
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
16:30
RMCF | $3.51 -3.7% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10